StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) income statement

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.41−0.04 (-9.87%)

Close on Nov 20, 2026Market cap $6.23MP/E –Yield –

See a number that looks wrong?